Juncture Wealth Strategies, LLC Neurocrine Biosciences Inc Transaction History
Juncture Wealth Strategies, LLC
- $298 Million
- Q3 2025
A detailed history of Juncture Wealth Strategies, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Juncture Wealth Strategies, LLC holds 4,671 shares of NBIX stock, worth $641,561. This represents 0.22% of its overall portfolio holdings.
Number of Shares
4,671
Previous 3,987
17.16%
Holding current value
$641,561
Previous $501,000
30.74%
% of portfolio
0.22%
Previous 0.18%
Shares
8 transactions
Others Institutions Holding NBIX
# of Institutions
657Shares Held
101MCall Options Held
290KPut Options Held
214K-
Black Rock Inc. New York, NY14.2MShares$1.95 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$1.35 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.57MShares$765 Million0.42% of portfolio
-
State Street Corp Boston, MA4.47MShares$614 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.09MShares$424 Million0.04% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.1B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...